MedTech Spectrum

Article Name Predictive Diagnostics

Lunit to Power Germany's Largest Private Radiology Network with AI Imaging

South Korea’s Lunit signs major deal to deploy its AI diagnostic software across RAD-x, enhancing radiology workflows in over 20 German locations.

08th May, 2025

FastWave Medical Secures IRB Approval for Sola™ Coronary Laser IVL System

Breakthrough intravascular lithotripsy device to begin first-in-human trials for treatment of calcified coronary artery disease

08th May, 2025

Applied Medical Launches RHAPSO™ and GEMINI® to Advance Minimally Invasive Surgery

New suture passing instruments designed to enhance efficiency and precision in laparoscopic and robotic procedures

08th May, 2025

Mucopolysaccharidosis Type I Market Projected for Steady Growth

DelveInsight forecasts an 8% CAGR from 2025 to 2034, driven by improved diagnostics and expanding treatment options.

08th May, 2025

Europe Embraces Health Data Sharing as Johnson & Johnson MedTech Survey Shows Rising Trust in Tech-Driven Care

Survey reveals strong public and professional confidence in digital health technologies to drive personalized treatment, surgical precision, and medical training across Europe.

08th May, 2025

Altamont Integrates AI into Radiology Reporting

Seamless AI-powered reporting enhances speed and accuracy in clinical workflows

07th May, 2025

SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine

Amid growing global pandemic concerns, SK bioscience partners with South Korea's national effort to advance rapid-response vaccine development against avian influenza threats.

07th May, 2025

Accuray Marks Milestone with First CyberKnife® SRS/SBRT Treatments in Austria

Innovative radiosurgery system debuts at Ordensklinikum Linz, advancing precision cancer care in the region

06th May, 2025

Implantica Expands RefluxStop™ Access with New Center of Excellence in Spain

Hospital Universitario Central de Asturias joins European network to offer innovative acid reflux implant as Implantica scales treatment reach across the region.

06th May, 2025

Aptamer Group and Neuro-Bio Adapt Saliva-Based Alzheimer’s Test to ELISA Format, Advancing Towards Commercialisation

The partnership aims to deliver a non-invasive, hospital-compatible diagnostic using Aptamer’s Optimer binders and Neuro-Bio’s novel early-stage biomarker, with commercial rollout targeted within 12–18 months.

06th May, 2025

Royal Marsden First to Use RaySearch Adaptive Radiotherapy in Cancer Care

UK hospital becomes first globally to treat patient with new module for online adaptive radiotherapy

05th May, 2025

PureHealth Posts $137.6M Q1 Profit Under Chairman H.E. Kamal Al Maazmi and CEO Farhan Malik

Middle East's largest healthcare group posts solid growth across all segments, fueled by rising patient volumes, tech innovation, and global expansion

02nd May, 2025

Peter Arduini Leads GE HealthCare Into FY25 With 51% Net Income Growth and $1B Share Repurchase Amid Global Uncertainty

With strong U.S. demand, a robust radiopharma rollout, and 4% organic revenue growth, CEO Peter Arduini highlights precision care strategy and innovation as GE HealthCare revises guidance under tariff pressures.

02nd May, 2025

Siemens Healthineers Powers Breast Cancer Detection in Indonesia with Launch of MAMMOMAT B.brilliant

Introduced at the Indonesian Women Imaging Society event, the new mammography system delivers rapid 50° tomosynthesis for greater diagnostic clarity, enabling earlier detection and improved outcomes for women nationwide.

02nd May, 2025

AMDI Launches Autolab™ HBH System to Transform Sample Preparation in Under 2 Minutes

Unveiled at ESCMID Global Congress 2025, the new Hyperbaric Heating-based platform eliminates the need for extraction kits—delivering faster, simpler, and cost-effective molecular workflows across diverse research and diagnostic applications.

14th April, 2025

Immunovia’s Next-Gen Blood Test Outperforms CA19-9 in Detecting Early-Stage Pancreatic Cancer

New results from the VERIFI study show Immunovia's test accurately detects 77% of early-stage cases and maintains strong specificity across diverse high-risk groups—strengthening commercial launch plans for Q3 2025.

25th March, 2025

VolitionRx Unveils Promising Data: Nu.Q® Immunoassay Detects 21 Cancers, Eyes Multi-Licensing Deals

With low false positives and broad detection capabilities, Volition’s Nu.Q® test could reshape the $20B liquid biopsy market, as the company advances licensing talks with major diagnostic players.

24th March, 2025